Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Brazzein, now FDA-approved, emerges as a zero-calorie sweetener potentially safe for diabetic and obese populations, requiring further study to validate its health impacts.
Cardiology May 17th 2024
Psych Congress Network
Recent research indicates an incremental risk of cardiomyopathy associated with extended stimulant use in ADHD treatment among young adults. Notably, this risk peaks at eight years of therapy, reinforcing the need for vigilant cardiovascular monitoring.
Pediatrics May 14th 2024
The New England Journal of Medicine
In a recent study, 91% of patients with transfusion-dependent β-thalassemia achieved independence from transfusions following treatment with Exagamglogene Autotemcel.
Hematology May 13th 2024
Rapunzel syndrome, though rare, presents significant challenges in diagnosis and treatment, involving both psychiatric and gastrointestinal expertise. Understanding its clinical and psychological aspects is vital for effective management.
Gastroenterology May 7th 2024
In a controlled trial conducted over a six-month period in Mali, subcutaneous administration of the monoclonal antibody L9LS to children aged 6 to 10 achieved an efficacy rate of up to 77% in preventing clinical malaria.
Allergy & Immunology May 6th 2024
Epoch Health
Recent CDC findings have confirmed the first known cases of HIV transmission through nonsterile microneedling procedures at an unlicensed spa, highlighting significant lapses in infection control practices.
Dermatology May 3rd 2024